How Asthra is taking CSR timelines from one month to less than 10 days

Every second counts when developing life-saving drugs.

Manual Clinical Study Report (CSR) authoring is time-consuming, costly, and prone to errors. A first draft can take, on average, 16 working days -- and any delay directly impacts regulatory submission timelines, which in turn delays time to market.

With patient access and revenue capture in the balance, we can no longer afford to spend weeks or months on a first draft.

So, how can we accelerate this process without compromising on accuracy or compliance?

In this whitepaper, Sangnan AI's Asthra offers a solution, and a glimpse at a faster, scalable future for clinical documentation teams.

What you'll find inside:

• Why existing authoring solutions are falling short, and how this can change

• Automating CSR first-draft generation with 1 click

• How Asthra can help cut down timelines by 40-60%